However, the 2019 European Society of Cardiology (ESC) Guidelines for the diagnosis and management of chronic coronary syndromes mentioned that the role of allopurinol, a representative of the XOR inhibitors, in reducing clinical events in CAD remains unclear [32]. Here, XDH is linked to coronary artery disorder.